Related Experiment Videos

Cellular transformation and malignancy induced by ras require c-jun

R Johnson1, B Spiegelman, D Hanahan

  • 1Hormone Research Institute, University of California, San Francisco 94143, USA.

Insights

Ras oncogene activation relies on the transcription factor AP-1, specifically c-Jun. Loss of c-Jun impairs Ras-driven cell transformation, but restoring c-Jun rescues these properties, confirming its critical role.

Area of Science:

  • Oncogenes and cancer biology
  • Molecular mechanisms of cell transformation
  • Transcription factor regulation

Background:

  • Ras is a key oncogene implicated in various cancers.
  • Activated Ras proteins induce the AP-1 transcription factor, a complex of Fos and Jun proteins.
  • Dysregulated AP-1 protein expression can lead to neoplastic transformation, suggesting AP-1 as a Ras effector.

Purpose of the Study:

  • To investigate the role of AP-1 as a critical effector of Ras-induced transformation.
  • To determine if c-Jun is essential for Ras-mediated cellular changes and tumorigenicity.

Main Methods:

  • Analysis of Ras-induced transcriptional responses in c-jun null fibroblasts.
  • Comparison of transformation characteristics (loss of contact inhibition, anchorage independence, tumorigenicity) between wild-type and c-jun null cells.
  • Restoration of c-Jun expression in c-jun null cells to assess rescue of transformation phenotypes.

Main Results:

  • Ras-induced transcriptional activation of AP-1-responsive genes was significantly impaired in c-jun null fibroblasts.
  • c-jun null cells exhibited a lack of key Ras transformation hallmarks compared to wild-type cells.
  • Forced expression of c-Jun restored contact inhibition, anchorage independence, and tumorigenicity in Ras-expressing c-jun null cells.
  • Tumorigenic variants arising from Ras-expressing c-jun null cells consistently showed restored AP-1 activity.

Conclusions:

  • c-Jun is a crucial effector for transformation induced by activated Ras proteins.
  • Genetic evidence supports c-Jun's essential role in mediating Ras-driven oncogenesis.
  • Targeting the Ras-c-Jun pathway may offer therapeutic strategies for Ras-driven cancers.

Related Concept Videos